Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor
- 21 May 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (7), 1644-1651
- https://doi.org/10.1038/s41423-021-00694-9
Abstract
Tumor necrosis factor (TNF) inhibitors have improved a lot the treatment of numerous diseases, with the well-known example of rheumatoid arthritis (RA). In the early 2000s, postmarketing data quickly revealed an alarming number of severe tuberculosis (TB) under such treatment. These findings were consistent with previous results in mice where TNF is essential for lymph node formation and granuloma organization. The effects of TNF inhibition on RA synovium structure are very similar to those on granuloma, with changes in cellular interactions, cytokine, and chemokine production. In addition to the role of TNF in granuloma, the interleukin (IL)-12/interferon (IFN)-γ pathway is required for an efficient host defense against TB. Primary and secondary immunodeficiencies affecting this pathway lead to severe bacillus Calmette-Guérin (BCG) reaction or full TB. Any chronic inflammation as in RA induces a systemic Th1 defect that predisposes to TB through specific downregulation of the IL-12Rß2 chain. When TNF inhibitors are initiated, this transiently increases this risk of TB, through effects on cellular interactions in a latent TB granuloma. At a later stage, when a better control disease activity is obtained, the risk of TB is reduced but not abrogated. Given the clear benefit from TNF inhibition, latent TB infection screening at baseline is essential for an optimal safety.Keywords
This publication has 111 references indexed in Scilit:
- Interleukin-18 and IL-18 Binding ProteinFrontiers in Immunology, 2013
- Anti-TNF treatment blocks the induction of T cell-dependent humoral responsesAnnals Of The Rheumatic Diseases, 2012
- Revisiting the role of the granuloma in tuberculosisNature Reviews Immunology, 2012
- Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assayAnnals Of The Rheumatic Diseases, 2011
- IL-12Rβ1 Deficiency in Two of Fifty Children with Severe Tuberculosis from Iran, Morocco, and TurkeyPLOS ONE, 2011
- IL-17 and Th17 cells in tuberculosisCytokine & Growth Factor Reviews, 2010
- Revisiting Human IL-12Rβ1 DeficiencyMedicine, 2010
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)Annals Of The Rheumatic Diseases, 2009
- Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patientsClinical Rheumatology, 2004
- Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expressionThe Journal of Pathology, 2004